United States · FDA National Drug Code directory
Tymlos
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70539-001_f1834fb1-55c0-46ca-9da4-d03e867b3b8b
- Product NDC
- 70539-001
- Form
- INJECTION, SOLUTION
- Composition / generic term
- abaloparatide
- Labeler
- Radius Health, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20170501
- Source listing expiry
- 20271231
Source-listed ingredients
- ABALOPARATIDE — 3.12 mg/1.56mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CARTRIDGE in 1 BOX, UNIT-DOSE (70539-001-02) / 1.56 mL in 1 CARTRIDGE (70539-001-01) · 70539-001-02
- 1 CARTRIDGE in 1 BOX, UNIT-DOSE (70539-001-98) / 1.56 mL in 1 CARTRIDGE (70539-001-99) · 70539-001-98
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →